Book here

The pace of scientific innovation in and around the life sciences has never been faster, and the implications of many of these innovations pose significant issues for policy-makers, especially for applications relating to human health.

How can we balance an accurate understanding of complex biomedical science against ethical, legal and social issues to develop robust and effective policy?

Join leading international experts to examine the practical impact of contemporary issues in law, ethics (and beyond) on policy-making for the life sciences and health. 

  • Law and policymaking for gene editing Prof Bartha Knoppers – Director, Centre of Genomics and Policy, McGill University 
  • Evidence, ethics and epistemology in policy-making for gene editing Dr Eric Meslin – President, Council of Canadian Academies 
Plus guest speakers

This half-day event begins with lunch and includes plenty of time for discussion, debate and networking. 

12:00 - 17:00, 25 May at the Møller Centre, Churchill College, Cambridge

Tickets: £50  Book here

Life Sciences & Society series

Healthcare is on the cusp of an exciting new future, but health systems must move quickly to meet these challenges and exploit the opportunities ahead. The series highlights the key areas where science and technology could transform disease prevention and care, examine barriers to implementation, and explore the policy implications of biomedical and digital innovations for health. 

The Life Sciences & Society series is an initiative of the PHG Foundation, in partnership with Cambridge University Health Partners and Hughes Hall.